Helius Therapeutics launches first products in Australia by Martin Lane October 15, 2024October 17, 2024 Helius Therapeutics has launched in the Australian market under the brand HTL on the third anniversary […]
Company news: Cann Group; Helius Therapeutics/Novachem; Elixinol/HFA by Martin Lane September 4, 2024September 5, 2024
RACGP bans medicinal cannabis firms from exhibiting at national conference by Steve Jones July 25, 2024July 25, 2024
NZ firm Aether Pacific inks Aussie distribution deal with Novachem by Martin Lane September 8, 2023April 30, 2024
Novachem expands distribution services to product sponsors by Steve Jones August 10, 2023April 30, 2024
Company news: Eqalis/Novachem; Cann Group; Vitura Health; Incannex; Lyphe Group by Steve Jones and Martin Lane March 1, 2023April 30, 2024
Novachem offers metered-dosing inhaler to Australian patients by Steve Jones December 21, 2022April 29, 2024
Modern medicine: can the dominance of oil and flower be challenged? by Steve Jones October 6, 2022April 29, 2024
We need to talk about flower – the vexing challenge of dried cannabis by Steve Jones September 21, 2022April 29, 2024
